(S)-(2-(aminomethyl)-4-(quinolin-3-yl)piperazin-1-yl)(1-(3-ethoxyphenyl)-2-(p-tolyl)-1H-imidazol-4-yl)methanone | 1127890-48-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪烷类
• 英文名称: (S)-(2-(aminomethyl)-4-(quinolin-3-yl)piperazin-1-yl)(1-(3-ethoxyphenyl)-2-(p-tolyl)-1H-imidazol-4-yl)methanone
• CAS: 1127890-48-5
• 化学式: C₃₃H₃₄N₆O₂
• 分子量: 546.672
• InChiKey: FGXHDZLDSIHSBQ-NDEPHWFRSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.08
• 重原子数：
  41.0
• 可旋转键数：
  7.0
• 环数：
  6.0
• sp3杂化的碳原子比例：
  0.24
• 拓扑面积：
  89.51
• 氢给体数：
  1.0
• 氢受体数：
  7.0

反应信息

• 作为反应物：
  描述：

  (S)-(2-(aminomethyl)-4-(quinolin-3-yl)piperazin-1-yl)(1-(3-ethoxyphenyl)-2-(p-tolyl)-1H-imidazol-4-yl)methanone 、 甲基磺酰氯 在 N,N-二异丙基乙胺 作用下， 以 二氯甲烷 为溶剂， 生成 N-(((R)-1-(1-(3-ethoxyphenyl)-2-p-tolyl-1H-imidazole-4-carbonyl)-4-(quinolin-3-yl)piperazin-2-yl)methyl)methanesulfonamide
  参考文献：
  名称：

  2-Substituted piperazine-derived imidazole carboxamides as potent and selective CCK1R agonists for the treatment of obesity

  摘要：

  The discovery and structure-activity relationship of 1,2-diarylimidazole piperazine carboxamides bearing polar side chains as potent and selective cholecystokinin 1 receptor (CCK1R) agonists are described. Optimization of this series resulted in the discovery of isopropyl carboxamide 40, a CCK1R agonist with sub-nanomolar functional and binding activity as well as excellent potency in a mouse overnight food intake reduction assay. (C) 2008 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2008.07.083
• 作为产物：
  描述：

  在 palladium dihydroxide 、 氢气 作用下， 以 甲醇 为溶剂， 生成 (S)-(2-(aminomethyl)-4-(quinolin-3-yl)piperazin-1-yl)(1-(3-ethoxyphenyl)-2-(p-tolyl)-1H-imidazol-4-yl)methanone
  参考文献：
  名称：

  2-Substituted piperazine-derived imidazole carboxamides as potent and selective CCK1R agonists for the treatment of obesity

  摘要：

  The discovery and structure-activity relationship of 1,2-diarylimidazole piperazine carboxamides bearing polar side chains as potent and selective cholecystokinin 1 receptor (CCK1R) agonists are described. Optimization of this series resulted in the discovery of isopropyl carboxamide 40, a CCK1R agonist with sub-nanomolar functional and binding activity as well as excellent potency in a mouse overnight food intake reduction assay. (C) 2008 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2008.07.083